Orchid Pharma’s wholly-owned subsidiary - Orchid Europe, UK, has entered into a long term financial arrangement to avail up to $800 million as loan with Line Trust International, Guernsey, UK. This funding will help the company explore new growth opportunities while enabling the current business achieve incremental value.
Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).
